Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02199548 · ClinicalTrials.gov registry record
The Good Patient Study
A clinical trial of Solid Tumor and Brain Tumor, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 43
- Enrollment target
- 2
- Study locations
NCT02199548: Completed study of Solid Tumor and Brain Tumor, sponsored by St. Jude Children's Research Hospital.
NCT02199548 is a study of Solid Tumor and Brain Tumor that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 43 participants, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02199548, a study of Solid Tumor and Brain Tumor, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
Adolescents with cancer weigh multiple influences in medical decision-making, including their own best interest, the perceived wishes of family members, and the interpreted preferences of the health care team. Parents of children with cancer often describe themselves as trying to be a good parent in making decisions in the child's best interest. Adolescents with cancer often describe themselves as trying to be a good patient and good child in making decisions in accord with how they believe a good patient and good child would decide. Among the challenges of caring for adolescents is the reality that the formative relational influences in adolescents' decision-making are both complex and unique due to adolescent patients' social networks and relational roles. Delineating adolescents' definitions of being a good patient, a good child, a good sibling, and a good friend may enable the care team to better understand the formative decisional influences relevant to adolescents with cancer. Expanding knowledge about the decision making constructs relevant to adolescents with cancer and recognizing the role of these social constructs in medical interactions has the potential for development of a comprehensive care model that methodically evaluates the self-assessed decision making influences and needs of adolescents at various stages in oncology care. This qualitative construct-defining study represents an initial step in the development of enhanced interventions for improved psychosocial support in this vulnerable population.
Primary Outcome
Describe the ways relationships and social interactions may factor into adolescent study participants' approach to decisions.
Conditions Studied
Interventions
- OTHER Interview
Study Locations (2)
District of Columbia
- Children's National Health System - Washington D.C.
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-05 |
What the finished NCT02199548 record still lists
NCT02199548 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 221-participant average among 196 other Solid Tumor trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT02199548 reports a single indexed study location in District of Columbia, Tennessee.
Frequently Asked Questions
What is clinical trial NCT02199548 about?
NCT02199548 is a clinical study titled "The Good Patient Study". Adolescents with cancer weigh multiple influences in medical decision-making, including their own best interest, the perceived wishes of family members, and the interpreted preferences of the health care team. Parents of children with cancer often describe themselves as trying to be a good parent in...
What is the current status of trial NCT02199548?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2014-07. Estimated completion is 2015-05.
What conditions does trial NCT02199548 study?
This clinical trial studies the following conditions: Solid Tumor, Brain Tumor, Hematological Malignancies.
What interventions are being tested in trial NCT02199548?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT02199548?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02199548 being conducted?
This trial has 2 study locations across District of Columbia, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02199548's enrollment target sits among peer trials
43 138th of 196 higher than 59 of 196 other Solid Tumor trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Solid Tumor trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
RECRUITING · Phase 2
-
Dabrafenib and/or Trametinib Rollover Study
RECRUITING · Phase 4
-
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
RECRUITING · Phase 3
-
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
RECRUITING · Phase 1
-
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia